Surely this has to be one of the best risk vs. reward probability plays currently on the market. The mind boggles that we are back below the (utterly inadequate) offer price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025